SHANNON MOHOLLEN: Open Payments
NPI 1659962207 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$670 in 31 payments from 16 companies in 2025. Trend: 2023 $874 · 2024 $1,050 · 2025 $670
Food & beverage: $670
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $96 |
| Valinor Pharma, LLC | 4 | $88 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $84 |
| QOL Medical, LLC | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $53 |
| Collegium Pharmaceutical, Inc. | 3 | $49 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $33 |
| Lilly USA, LLC | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $27 |
Products named: NURTEC ODT, MOVANTIK, RELISTOR, Sucraid, JOURNAVX, TEZSPIRE, Belbuca, OMVOH.
Industry payments across DE — which companies pay providers there.
